Impact of the New Definition of Pulmonary Hypertension on the Prevalence of Primary Graft Dysfunction in Lung Transplant Recipients
2024; Elsevier BV; Volume: 33; Issue: 4 Linguagem: Inglês
10.1016/j.hlc.2023.12.019
ISSN1444-2892
AutoresVíctor Manuel Mora Cuesta, Amaya Martínez-Meñaca, David Iturbe Fernández, Sandra Tello-Mena, Sheila Izquierdo-Cuervo, Tamara García Camarero, Aritz Gil Ongay, Laura Sánchez-Moreno, Pilar Alonso‐Lecue, Sara Naranjo-Gozalo, José Manuel Cifrián Martínez,
Tópico(s)Organ Transplantation Techniques and Outcomes
ResumoPulmonary hypertension (PH) secondary to lung disease (Group-3 PH) is the second leading cause of PH. The role of PH as a risk factor for primary graft dysfunction (PGD) following lung transplant (LT) is controversial.
Referência(s)